import React from "react";

export const ReferencesData = [
  {
    id: "index",
    references: [
      {
      copy: <>Flume PA, Chalmers JD, Olivier KN. Advances in bronchiectasis: endotyping, genetics, microbiome, and disease heterogeneity. <em>Lancet</em>. 2018;392(10150):880-890.</>
      },
      {
      copy: <>Dente FL, Bilotta M, Bartoli ML, et al. Neutrophilic bronchial inflammation correlates with clinical and functional findings in patients with noncystic fibrosis bronchiectasis. <em>Mediators Inflamm</em>. 2015;2015:642503.</>
      },
      {
      copy: <>Effah CY, Drokow EK, Agboyibor C, et al. Neutrophil-dependent immunity during pulmonary infections and inflammations. <em>Front Immunol</em>. 2021;12:689866.</>
      },
      {
      copy: <>Rosales C. Neutrophils at the crossroads of innate and adaptive immunity. <em>J Leukoc Biol</em>. 2020;108(1):377-396.</>
      },
      {
      copy: <>Keir HR, Chalmers JD. Pathophysiology of bronchiectasis. <em>Semin Respir Crit Care Med</em>. 2021;42(4):499-512.</>
      },
      {
      copy: <>Chalmers JD, Moffitt KL, Suarez-Cuartin G, et al. Neutrophil elastase activity is associated with exacerbations and lung function decline in bronchiectasis. <em>Am J Respir Crit Care Med</em>. 2017;195(10):1384-1393.</>
      },
      {
      copy: <>Polverino E, Goeminne PC, McDonnell MJ, et al. European Respiratory Society guidelines for the management of adult bronchiectasis. <em>Eur Respir J</em>. 2017;50(3):1700629.</>
      },
      {
      copy: <>O’Donnell AE. Bronchiectasis—a clinical review. <em>N Engl J Med</em>. 2022;387(6):533-545.</>
      },
      {
      copy: <>Chalmers JD, Aliberti S, Filonenko A, et al. Characterization of the “frequent exacerbator phenotype” in bronchiectasis. <em>Am J Respir Crit Care Med</em>. 2018;197(11):1410-1420.</>
      },
    ],
  },
  {
    id: "DiseaseOverview",
    references: [
        {
        copy: <>Chalmers JD, Chang AB, Chotirmall SH, Dhar R, McShane PJ. Bronchiectasis. <em>Nat Rev Dis Primers</em>. 2018;4(1):45.</>,
        },
        {
        copy: <>Keir HR, Chalmers JD. Pathophysiology of bronchiectasis. <em>Semin Respir Crit Care Med</em>. 2021;42(4):499-512.</>,
        },
        {
        copy: <>Data on file. Insmed Incorporated. Bridgewater, NJ.</>,
        },
        {
        copy: <>Polverino E, Goeminne PC, McDonnell MJ, et al. European Respiratory Society guidelines for the management of adult bronchiectasis. <em>Eur Respir J</em>. 2017;50(3):1700629.</>,
        },
        {
        copy: <>O’Donnell AE. Bronchiectasis—a clinical review. <em>N Engl J Med</em>. 2022;387(6):533-545.</>,
        },
        {
        copy: <>Cohen R, Shteinberg M. Diagnosis and evaluation of bronchiectasis. <em>Clin Chest Med</em>. 2022;43(1):7-22.</>,
        },
        {
        copy: <>Polverino E, Dimakou K, Hurst J, et al. The overlap between bronchiectasis and chronic airway diseases: state of the art and future directions. <em>Eur Respir J</em>. 2018;52(3):1800328.</>,
        },
        {
        copy: <>Chalmers JD, Sethi S. Raising awareness of bronchiectasis in primary care: overview of diagnosis and management strategies in adults. <em>NPJ Prim Care Respir Med</em>. 2017;27(1):18.</>,
        },
        {
        copy: <>Chan ED, Wooten WI III, Hsieh EWY, et al. Diagnostic evaluation of bronchiectasis. <em>Respir Med X</em>. 2019;1:100006.</>,
        },
        {
        copy: <>Flume PA, Chalmers JD, Olivier KN. Advances in bronchiectasis: endotyping, genetics, microbiome, and disease heterogeneity. <em>Lancet</em>. 2018;392(10150):880-890.</>,
        },
        {
        copy: <>Aliberti S, Goeminne PC, O’Donnell AE, et al. Criteria and definitions for the radiological and clinical diagnosis of bronchiectasis in adults for use in clinical trials: international consensus recommendations. <em>Lancet Respir Med</em>. 2022;10(3):298-306.</>,
        },
        {
        copy: <>Chalmers JD, Aliberti S, Filonenko A, et al. Characterization of the “frequent exacerbator phenotype” in bronchiectasis. <em>Am J Respir Crit Care Med</em>. 2018;197(11):1410-1420.</>,
        },
        {
        copy: <>Dudgeon EK, Crichton M, Chalmers JD. “The missing ingredient”: the patient perspective of health related quality of life in bronchiectasis: a qualitative study. <em>BMC Pulm Med</em>. 2018;18(1):81.</>,
        },
        {
        copy: <>Hill AT, Haworth CS, Aliberti S, et al; for the EMBARC/BRR definitions working group. Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical research. <em>Eur Respir J</em>. 2017;49(6):1700051.</>,
        },
        {
          copy: <>Flume PA, Feliciano J, Lucci M, et al. Pulmonary exacerbations in insured patients with bronchiectasis over 2 years. <em>ERJ Open Res</em>. 2023;00021-02023.</>
        },
        {
        copy: <>Chalmers JD, Goeminne P, Aliberti S, et al. The Bronchiectasis Severity Index: an international derivation and validation study. <em>Am J Respir Crit Care Med</em>. 2014;189(5):576-585.</>,
        },
        {
        copy: <>Jones PW, Quirk FH, Baveystock CM. The St George’s Respiratory Questionnaire. <em>Respir Med</em>. 1991;85(suppl B):25-31.</>,
        },
    ],
  },
  {
    id: "Pathophysiology",
    references: [
      {
      copy: (
      <>Flume PA, Chalmers JD, Olivier KN. Advances in bronchiectasis: endotyping, genetics, microbiome, and disease heterogeneity. <em>Lancet</em>. 2018;392(10150):880-890.</>
      ),
      },
      {
      copy: (
      <>O’Donnell AE. Bronchiectasis—a clinical review. <em>N Engl J Med</em>. 2022;387(6):533-545.</>
      ),
      },
      {
      copy: (
      <>Keir HR, Chalmers JD. Pathophysiology of bronchiectasis. <em>Semin Respir Crit Care Med</em>. 2021;42(4):499-512.</>
      ),
      },
      {
      copy: (
      <>Chalmers JD, Chang AB, Chotirmall SH, Dhar R, McShane PJ. Bronchiectasis. <em>Nat Rev Dis Primers</em>. 2018;4(1):45.</>
      ),
      },
      {
      copy: (
      <>Polverino E, Goeminne PC, McDonnell MJ, et al. European Respiratory Society guidelines for the management of adult bronchiectasis. <em>Eur Respir J</em>. 2017;50(3):1700629.</>
      ),
      },
      {
      copy: (
      <>Pham CTN. Neutrophil serine proteases fine-tune the inflammatory response. <em>Int J Biochem Cell Biol</em>. 2008;40(6-7):1317-1333.</>
      ),
      },
      {
      copy: (
      <>Bedi P, Davidson DJ, McHugh BJ, Rossi AG, Hill AT. Blood neutrophils are reprogrammed in bronchiectasis. <em>Am J Respir Crit Care Med</em>. 2018;198(7):880-890.</>
      ),
      },
      {
      copy: (
      <>Chalmers JD, Chotirmall SH. Bronchiectasis: new therapies and new perspectives. <em>Lancet Respir Med</em>. 2018;6(9):715-726.</>
      ),
      },
      {
      copy: (
      <>Fine N, Tasevski N, McCulloch CA, Tenenbaum HC, Glogaur M. The neutrophil: constant defender and first responder. <em>Front Immunol</em>. 2020;11:571085.</>
      ),
      },
      {
      copy: (
      <>Gardiner P, Wikell C, Clifton S, Shearer J, Benjamin A, Peters SA. Neutrophil maturation rate determines the effects of dipeptidyl peptidase 1 inhibition on neutrophil serine protease activity. <em>Br J Pharmacol</em>. 2016;173(15):2390-2401.</>
      ),
      },
      {
      copy: (
      <>Dente FL, Bilotta M, Bartoli ML, et al. Neutrophilic bronchial inflammation correlates with clinical and functional findings in patients with noncystic fibrosis bronchiectasis. <em>Mediators Inflamm</em>. 2015;2015:642503.</>
      ),
      },
      {
      copy: (
        <>Effah CY, Drokow EK, Agboyibor C, et al. Neutrophil-dependent immunity during pulmonary infections and inflammations. <em>Front Immunol</em>. 2021;12:689866.</>
      ),
      },
      {
      copy: (
      <>Chalmers JD, Moffitt KL, Suarez-Cuartin G, et al. Neutrophil elastase activity is associated with exacerbations and lung function decline in bronchiectasis. <em>Am J Respir Crit Care Med</em>. 2017;195(10):1384-1393.</>
      ),
      },
    ],
  },
  {
    id: "TakeAction",
    references: [
      {
      copy: <>Chalmers JD, Aliberti S, Filonenko A, et al. Characterization of the “frequent exacerbator phenotype” in bronchiectasis. <em>Am J Respir Crit Care Med</em>. 2018;197(11):1410-1420.</>
      },
      {
      copy: <>Polverino E, Goeminne PC, McDonnell MJ, et al. European Respiratory Society guidelines for the management of adult bronchiectasis. <em>Eur Respir J</em>. 2017;50(3):1700629.</>
      },
      {
      copy: <>Chalmers JD, Chang AB, Chotirmall SH, Dhar R, McShane PJ. Bronchiectasis. <em>Nat Rev Dis Primers</em>. 2018;4(1):45.</>
      },
      {
      copy: <>Flume PA, Chalmers JD, Olivier KN. Advances in bronchiectasis: endotyping, genetics, microbiome, and disease heterogeneity. <em>Lancet</em>. 2018;392(10150):880-890.</>
      },
      {
      copy: <>Boaventura R, Sibila O, Agusti A, Chalmers JD. Treatable traits in bronchiectasis. <em>Eur Respir J</em>. 2018;52(3):1801269.</>
      },
      {
      copy: <>Keir HR, Chalmers JD. Pathophysiology of bronchiectasis. <em>Semin Respir Crit Care Med</em>. 2021;42(4):499-512.</>
      },
      {
      copy: <>O’Donnell AE. Bronchiectasis—a clinical review. <em>N Engl J Med</em>. 2022;387(6):533-545.</>
      },
      {
      copy: <>Chalmers JD, Chotirmall SH. Bronchiectasis: new therapies and new perspectives. <em>Lancet Respir Med</em>. 2018;6(9):715-726.</>
      },
      {
      copy: <>Cohen R, Shteinberg M. Diagnosis and evaluation of bronchiectasis. <em>Clin Chest Med</em>. 2022;43(1):7-22.</>
      },
      {
      copy: <>Aksamit TR, O’Donnell AE, Barker A, et al. Adult patients with bronchiectasis: a first look at the US Bronchiectasis Research Registry. <em>Chest</em>. 2017;151(5):982-992.</>
      },
      {
      copy: <>Kapur N, Petsky HL, Bell S, Kolbe J, Chang AB. Inhaled corticosteroids for bronchiectasis. <em>Cochrane Database Syst Rev</em>. 2018;5(5):CD000996.</>
      },
      {
      copy: <>Hill AT, Sullivan AL, Chalmers JD, et al. British Thoracic Society Guideline for bronchiectasis in adults. <em>Thorax</em>. 2019;74(suppl 1):1-69.</>
      },
      {
      copy: <>O’Neill K, O’Donnell AE, Bradley JM. Airway clearance, mucoactive therapies and pulmonary rehabilitation in bronchiectasis. <em>Respirology</em>. 2019;24(3):227-237.</>
      },
      {
      copy: <>Lee AL, Burge AT, Holland AE. Airway clearance techniques for bronchiectasis (review). <em>Cochrane Database Syst Rev</em>. 2015;2015(11):CD008351.</>
      },
      {
      copy: <>Basavaraj A, Choate R, Addrizzo-Harris D, et al. Airway clearance techniques in bronchiectasis: analysis from the United States Bronchiectasis and Non-TB Mycobacteria Research Registry. <em>Chest</em>. 2020;158(4):1376-1384.</>
      },
      {
      copy: <>Chan ED, Wooten WI III, Hsieh EWY, et al. Diagnostic evaluation of bronchiectasis. <em>Respir Med X</em>. 2019;1:100006.</>
      },
      {
      copy: <>Aliberti S, Goeminne PC, O’Donnell AE, et al. Criteria and definitions for the radiological and clinical diagnosis of bronchiectasis in adults for use in clinical trials: international consensus recommendations. <em>Lancet Respir Med</em>. 2022;10(3):298-306.</>
      },
      {
      copy: <>Weycker D, Hansen GL, Seifer FD. Prevalence and incidence of noncystic fibrosis bronchiectasis among US adults in 2013. <em>Chron Respir Dis</em>. 2017;14(4):377-384.</>
      },
    ],
  },
];
